Open AccessVEGF-A and cardiac autonomic function in newly diagnosed type 2 diabetes mellitus: A cross-sectional study at a tertiary care center
Author(s) -
Suresh Ravichandran,
Shival Srivastav,
Prathamesh Kamble,
Shailja Chambial,
Ravindra Shukla,
Praveen Sharma,
Rajesh Sharma
Publication year - 2019
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_537_19
Subject(s) - medicine , diabetes mellitus , biomarker , cardiology , heart rate variability , vascular endothelial growth factor , autonomic function , type 2 diabetes mellitus , cardiac function curve , endocrinology , heart rate , heart failure , vegf receptors , blood pressure , biochemistry , chemistry
Cardiac autonomic neuropathy (CAN) is a key complication of type 2 diabetes mellitus (Ty2DM). Vascular endothelial-derived growth factor (VEGF-A) plays a key role in diabetic macrovascular and microvascular complications. It is shown to be elevated in diabetic neuropathy and has the potential to serve as a biomarker in Ty2DM. We evaluated VEGF-A levels and cardiac autonomic function in newly diagnosed Ty2DM patients.